What is the return on investment associated with diabetes disease management? A report from one managed care organization in Pennsylvania, USA

Disease Management and Health Outcomes

Volumn 11, Issue 9, 2003, Pages 565-570

  Sidorov, Jaan ^a,b,c   Paulick, Peter ^a   Sobel, Lila ^a  

^a Geisinger Health Plan ^*  (United States)

^b Care Coordination Program   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; DATA ANALYSIS; DIABETES MELLITUS; HEALTH CARE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HUMAN; INVESTMENT; MARKET; NURSE; PATIENT CARE; PATIENT EDUCATION; PHYSICIAN; PRIMARY MEDICAL CARE; REVIEW; UNITED STATES;

EID: 0141426782     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200311090-00004     Document Type: Review

References (28)

1. Ellrodt G, Cook DJ, Lee J, et al. Evidence-based disease management. JAMA 1997; 278: 1687-92
2. Matheson D, Robinson T. Disease management takes flight [online]. Boston Consulting Group. Available from URL: http://www.bcg.com/publications/files/disease-management_taxes_fiight_oct_od. pdf [Accessed 2003 Jul 28]
3. Bodenheimer TS, Grumback K. Capitation or decapitation: keeping your head in changing times. JAMA 1996; 276: 1025-31
4. Mazze RS, Etzwiler DD, Strock E, et al. Staged diabetes management: towards an integrated model of diabetes care. Diabetes Care 1994; 17 Suppl. 1: 56-66
5. American Diabetes Association. Diabetes 1996 Vital Statistics. Alexandria (VA): American Diabetes Association, 1996
6. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 1992; 78: 809A-12A
7. Center for Economic Studies in Medicine. Direct and indirect costs of diabetes in the United States in 1992. Alexandria (VA): American Diabetes Association, 1993
8. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. Diabetes Care 1998; 21: 518-24
9. American Diabetes Association. Economic consequences of diabetes mellitus in the United States. Diabetes Care 1998; 21: 296-309
10. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
11. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6 year study. Diabetes Res Clin Pract 1995; 28: 103-17
12. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM): results of a feasibility trial. Diabetes Care 1995; 18: 1113-23
13. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75: 894-903
14. Vijan S, Hofer TP, Hayward RA: Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788-95
15. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-9
16. Krolewski A, Laffel L, Krolewski M, et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-5
17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998; 352: 847-53
18. Gaede P, Vedel P, Larsen N, et al. Multifactorial interventions and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93
19. Kenny SJ, Aubert RC, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: Harris MI, Cowie CC, Stern MP, et al., editors. Diabetes in America. 2nd ed. Bethesda (MD): National Institutes of Health, 1995: 47-67
20. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness: which ones work? Meta-analysis of published reports. BMJ 2002; 325: 925-32
21. Sommers LS, Marton KI, Barbaccia JC, et al. Physician, nurses and social worker collaboration in primary care for chronically ill seniors. Arch Intern Med 2000; 160: 1825-33
22. Kabasakalian LM, Hassett RM. A nurse-driven, carve-in approach for managing complex chronic conditions. J Clin Outcomes Manage 1999; 6: 26-30
23. Selby JV, Ray GT, Zhang D, et al. The excess costs of medical care of patients with diabetes mellitus in a managed care population. Diabetes Care 1997; 20: 1396-402
24. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997; 20: 725-34
25. Herman WH, Eastman RC. The effects of treatment on direct costs of diabetes. Diabetes Care 1998; 21 Suppl. 3: C19-24
26. Testa MA, Simponson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled double blind trial. JAMA 1998; 280: 1490-6
27. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization: efficacy of care management using cluster visits. Diabetes Care 1999; 22: 2011-7
28. Internal communication: The Myers Group. Geisinger Health Plan, Provider Satisfaction Survey, 2002 Project Guide Book